MedPath

Clinical study to compare effects radiation alone and radiation with temozolomide in patients with brain metastasis from lung and breast cancer

Phase 3
Conditions
Health Condition 1: null- Cases of carcinoma lung and breast with newly diagnosed brain metastasis
Registration Number
CTRI/2013/06/003746
Lead Sponsor
Regional cancer centreThiruvananthapuram
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
96
Inclusion Criteria

1.patients registered at Regional cancer centre, Thiruvananthapuram

2. Age 18-70Years

3.KPS >70

4.Histologically proven primary cancer from lung&breast

5.Documented brain metastasis (contrast enhanced CT or Gd enhanced MRI)

6.Not suitable for surgery or stereotactic radiosurgery

7. Life expectancy >3months

8.Normal biochemical and hematologic parameters

9.informed consent

10.As and when indicated chemotherapy for systemic progression will be permitted according to clinical indication on completion of radiotherapy

Exclusion Criteria

EXCLUSION CRITERIA

1.prior radiothrapy for brain metastasis

2.severe intercurrent medical illness

-symptomatic heart disease

-uncontrolled diabetes mellitus

3. pregnancy/lactating women

4.Known psychiatric illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath